FDA Inspection
Senador Laboratories Private LimitedFDA Inspection 1037438 - Senador Laboratories Private Limited - November 24, 2017
Record Details
This FDA Inspection record concerns Senador Laboratories Private Limited, with an inspection on November 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 24, 2017
- Product Type
- Drugs
View Company Profile
ID · b3dbccf3-c706-4a9a-a2cb-6c15db87e7ae
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1037438
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Senador Laboratories Private Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 24, 2025 | Not classified | Office of Inspections and Investigations | |
| September 16, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 29, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Senador Laboratories Private Limited
- FDA Inspection 1305216 - 2025-11-24
- FDA Inspection 1107337 - 2019-09-16
- FDA Inspection 1028107 - 2017-08-29
- FDA Inspection 891441 - 2014-07-25
- FDA Inspection 790200 - 2012-06-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.